The Ross Prize is given by the Feinstein Institutes for Medical Research to scientists who have made a demonstrable impact on understanding human disease pathogenesis and/or treatment in the field of molecular medicine. Krainer is being recognized for pioneering antisense therapy in clinical use, and its successful application to spinal muscular atrophy (SMA).
“I am very grateful and honored to receive this year’s Ross Prize,” said Krainer. “My trainees and I feel privileged that our research has helped SMA patients. In keeping with the intent of this generous award, we will redouble our efforts to explore new ways to address unmet medical needs.”
“Dr. Krainer’s remarkable discoveries have revolutionized the treatment of a devastating, crippling pediatric illness. His inventions are already giving children the ability to crawl, walk, and live their lives,” said Kevin J. Tracey, President and CEO of the Feinstein Institute.